STUDIES |
[View FULLTEXT]
|
|
| Year : 1996 | Volume
: 62
| Issue : 1 | Page : 16-18 |
Rifampicin and dapsone in superficial pustular folliculitis
PVS Prasad
,
Correspondence Address:
PVS Prasad
Fifty male patients diagnosed to have superficial pustular folliculitis (SPF) were included in an open trial to study the effects of rifampicin vs dapsone. Rifampicin, in a dose of 10mg/kg body weight for a period of 8 weeks was given for 25 patients in phase I and the drug cleared the lesions in 72%. Dapsone in a dose of 100 mg/day produced moderate response in 20% only. 17 patients who did not clear with dapsone were started on rifampicin (phase II) and 7/17 showed marked improvement. Remissions with rifampicin ranged from 3-9 months or longer. In patients who relapsed, a second course of the drug was effective.
How to cite this article:
Prasad P. Rifampicin and dapsone in superficial pustular folliculitis.Indian J Dermatol Venereol Leprol 1996;62:16-18
|
How to cite this URL:
Prasad P. Rifampicin and dapsone in superficial pustular folliculitis. Indian J Dermatol Venereol Leprol [serial online] 1996 [cited 2013 May 26 ];62:16-18
Available from: http://www.ijdvl.com/article.asp?issn=0378-6323;year=1996;volume=62;issue=1;spage=16;epage=18;aulast=Prasad;type=0 |
|
